BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36838599)

  • 1. Anemoside A3 Inhibits Macrophage M2-Like Polarization to Prevent Triple-Negative Breast Cancer Metastasis.
    Liu P; Liu Y; Chen L; Fan Z; Luo Y; Cui Y
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatilla Saponins Inhibit Experimental Lung Metastasis of Melanoma via Targeting STAT6-Mediated M2 Macrophages Polarization.
    Yang X; Wu M; Yan X; Zhang C; Luo Y; Yu J
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175092
    [No Abstract]   [Full Text] [Related]  

  • 3. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemoside A3 activates TLR4-dependent M1-phenotype macrophage polarization to represses breast tumor growth and angiogenesis.
    Yin L; Fan Z; Liu P; Chen L; Guan Z; Liu Y; Luo Y
    Toxicol Appl Pharmacol; 2021 Dec; 432():115755. PubMed ID: 34673087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages.
    Mei M; Tang L; Zhou H; Xue N; Li M
    Eur J Pharmacol; 2023 Nov; 959():176076. PubMed ID: 37797675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.
    Chen LM; Yang PP; Al Haq AT; Hwang PA; Lai YC; Weng YS; Chen MA; Hsu HL
    J Biomed Sci; 2022 Sep; 29(1):70. PubMed ID: 36109724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
    Xu F; Cui WQ; Wei Y; Cui J; Qiu J; Hu LL; Gong WY; Dong JC; Liu BJ
    J Exp Clin Cancer Res; 2018 Aug; 37(1):207. PubMed ID: 30157903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.
    Min L; Wang H; Qi H
    Am J Transl Res; 2022; 14(3):1551-1566. PubMed ID: 35422920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atractylenolide II inhibits tumor-associated macrophages (TAMs)-induced lung cancer cell metastasis.
    Zhang Y; Liu Y; Wang J; Jiang Z; Zhang L; Cui Y; Zhao D; Wang Y
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):227-237. PubMed ID: 35166628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran Sulfate Inhibits Angiogenesis and Invasion of Gastric Cancer by Interfering with M2-type Macrophages Polarization.
    Guo J; Li Z; Ma Q; Li M; Zhao Y; Li B; Tao Y; Xu Y; Huang Y
    Curr Cancer Drug Targets; 2022; 22(11):904-918. PubMed ID: 35792124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.
    Jia X; Yu F; Wang J; Iwanowycz S; Saaoud F; Wang Y; Hu J; Wang Q; Fan D
    Breast Cancer Res Treat; 2014 Nov; 148(2):291-302. PubMed ID: 25311112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
    Tariq M; Zhang JQ; Liang GK; He QJ; Ding L; Yang B
    Acta Pharmacol Sin; 2017 Nov; 38(11):1501-1511. PubMed ID: 29022575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling.
    Cheng Y; Zhong X; Nie X; Gu H; Wu X; Li R; Wu Y; Lv K; Leung GP; Fu C; Lee SM; Zhang J; Li J
    Phytomedicine; 2023 Jun; 114():154757. PubMed ID: 37011418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes derived from rapamycin-treated 4T1 breast cancer cells induced polarization of macrophages to M1 phenotype.
    Ghalavand M; Moradi-Chaleshtori M; Dorostkar R; Mohammadi-Yeganeh S; Hashemi SM
    Biotechnol Appl Biochem; 2023 Oct; 70(5):1754-1771. PubMed ID: 37254633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.
    Li Y; Han X; Lin Z; Wang C; Fu Z; Sun Q; Li C
    Cell Mol Life Sci; 2023 May; 80(6):165. PubMed ID: 37237244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
    Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
    Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-metastatic effects of AGS-30 on breast cancer through the inhibition of M2-like macrophage polarization.
    Li J; Liu Z; Wu X; Lee SM; Seto SW; Zhang J; Zhou GC; Leung GP
    Biomed Pharmacother; 2024 Mar; 172():116269. PubMed ID: 38367549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD‑L1 mediates triple‑negative breast cancer evolution via the regulation of TAM/M2 polarization.
    Meng Z; Zhang R; Wu X; Zhang M; Jin T
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages.
    Yao Z; Zhang J; Zhang B; Liang G; Chen X; Yao F; Xu X; Wu H; He Q; Ding L; Yang B
    Pharmacol Res; 2018 Jul; 133():121-131. PubMed ID: 29730267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.